GLEPID PLUS

This brand name is authorized in Nigeria.

Active ingredients

The drug GLEPID PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin
2	Glimepiride UNII 6KY687524K - GLIMEPIRIDE
	Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
	Read more about Glimepiride

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6887	Tablet	Glepid Plus Tablet TAB 500 mg; 2 mg 3 x 10's (in strips)	Tablet Bilayer tablet (one layer prolonged release) 31 RNW-PP-250734 GLEPID PLUS TABLET GLIMEPIRIDE 2MG + METFORMIN 500MG METFORMIN 500MG, GLIMEPIRIDE 2MG, EXCIPIENTS QS B4-6887 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products 310 POM 2 3/2/2022 SEAL HEALTHCARE LIMITED, 2, ASIMOLOWE STREET, OFF 5TH AVENUE, ABESAN ESTATE, LAGOS 80204011 femoade4real@yahoo.com FINECURE PHARMACEUTICAL LTD, VILLAGE SHIMLA PISTAUR, MALSA ROAD, KICHHA, UDHAMSINGH NAGAR, UTTARAKHAND-263148,INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BA02	Metformin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6887